# Intravitreal Injections-related Anxiety

> **NCT02035722** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 73 (actual)

## Conditions studied

- Age-related Macular Degeneration

## Interventions

- **BEHAVIORAL:** Printed materials
- **BEHAVIORAL:** Video

## Key facts

- **NCT ID:** NCT02035722
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-06
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2015-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02035722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02035722, "Intravitreal Injections-related Anxiety". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02035722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*